Close ✕
Health St. Louis
Photo: The Guardian

Blood Biomarker Offers a Clue to Diagnosing CTE in Living Patients

On November 13, researchers at the medical school of Washington University in St. Louis said a blood test measuring eMTBR-tau243 may help identify chronic traumatic encephalopathy, or CTE, in living people. The disease is associated with repeated blows to the head and can currently be confirmed only by examining brain tissue after death.

The team examined stored blood from 11 people whose CTE had been confirmed at autopsy. Their levels of the protein fragment were higher than those of healthy people and increased with disease severity. The marker could separate people with advanced CTE from healthy people, but it did not reliably detect early-stage disease.

The researchers initially encountered the clue while studying tau, a protein that can become abnormal in Alzheimer’s disease and other conditions. One person with high levels of the fragment had advanced CTE but no Alzheimer’s disease recorded. The finding suggests the marker may have a role in studying CTE, but it is not a standalone diagnostic test, and the results have not been validated for clinical diagnosis.

Researchers said larger studies are needed to establish whether the connection holds. If confirmed, a blood test could help monitor people at risk and support trials of potential treatments. An outside neuropathologist called the result preliminary and cautioned that abnormal tau occurs in several brain diseases, which can make its significance difficult to separate.

Reported by The Guardian, The Philadelphia Inquirer.

Related stories

Top stories now

About